SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000904454-15-000061
Filing Date
2015-02-05
Accepted
2015-02-05 17:17:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G FOR ALDEYRA THERAPEUTICS BY JOHNSON & JOHNSON s13g_020215-aldeyra.htm SC 13G 72482
  Complete submission text file 0000904454-15-000061.txt   74239
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1212
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Subject) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88182 | Film No.: 15581130
SIC: 2834 Pharmaceutical Preparations